38
A.B. Caballero et al. / Inorganic Chemistry Communications 19 (2012) 36–38
(
c) C.R. Maldonado, C. Marin, F. Olmo, O. Huertas, M. Quirós, M. Sánchez-
high spin (S=5/2, g=2.008). Above 10 K, the magnetic susceptibility
3
−1
Moreno, M.J. Rosales, J.M. Salas, In vitro and in vivo trypanocidal evaluation
of nickel complexes with an azapurine derivative against Trypanosoma cruzi,
J. Med. Chem. 53 (2010) 6964–6972;
follows a Curie–Weiss law with C
m
=8.881 cm K mol
and θ=
−
12.4 K. Both, the negative temperature intercept and the decrease of
(
d) I. Lakomska, Molecular structure and antitumor activity of platinum(II) com-
plexes containing purine analogs, Inorg. Chim. Acta 362 (2009) 669–681;
e) J. Ruiz, M.D. Villa, N. Cutillas, G. López, C. de Haro, D. Bautista, V. Moreno, L.
Valencia, Palladium(II) and platinum(II) organometallic complexes with
4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor ac-
tivity of the platinum compounds, Inorg. Chem. 47 (2008) 4490–4505;
f) I. Lakomska, H. Kooijman, A.L. Spek, W. Shen, J. Reedijk, Mono- and dinuclear
platinum(II) compounds with 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine.
Structure, cytotoxic activity and reaction with 5′-GMP, J. Chem. Soc., Dalton
Trans. (2009) 10736–10741.
the magnetic effective moment at low temperatures are in agreement
with weak antiferromagnetic interactions in the compound. Taking
into account the crystal structure the experimental data were fitted to
a model of S=5/2 dimers, from which a satisfactory fit was obtained
(
−
1
with a coupling constant (J) value of −1.76 cm
between manganese ions through oxalate bridging ligand. The obtained
J value lies in the lower range found for others trans-MnO chromo-
phores bridged by bisbidentated oxalato ligands (−2.16bJb
for the interaction
(
4 2
N
[
6] (a) N. Zhang, S. Ayral-Kaloustian, T. Nguyen, J. Afragola, R. Hernández, J. Lucas, J.
Gibbons, C. Beyer, Synthesis and SAR of [1,2,4]triazolo[1,5-a]pyrimidines, a
class of anticancer agents with a unique mechanism of tubulin inhibition,
J. Med. Chem. 50 (2007) 319–327;
−
1
−
1.74 cm ), probably because the relatively long Mn···Mn distance
present in this compound (5.76 Å for compound 1 vs 5.54–5.71 Å for
other examples of oxalate bridged Mn(II) compounds) weakens the
antiferromagnetic exchange coupling [13].
(
b) G. Fischer, Recent progress in 1,2,4-triazolo[1,5-a]pyrimidine chemistry, Adv.
Heterocycl. Chem. 95 (2008) 143–219 and references therein;
(
c) R. Gujjar, A. Marwaha, F. El Mazouni, J. White, K.L. White, S. Creason, D.M.
Shackleford, J. Baldwin, W.N. Charman, F.S. Buckner, S. Charman, P.K. Rathod,
M.A. Phillips, Identification of a metabolically stable triazolopyrimidine-based
dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice,
J. Med. Chem. 52 (2009) 1864–1872;
Acknowledgments
This work was supported by the Junta de Andalucía (FQM-3705
and FQM-4228). A.B. Caballero is grateful for a FPU fellowship from
the Spanish Ministry of Education.
(
d) W. Tang, D.Q. Shi, Synthesis and herbicidal activity of O, O-dialkyl N-[2-(5,7-
dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yloxy)benzoxyl]-1-amino-1-
substitutedbenzyl phosphonates, J. Heterocycl. Chem. 47 (2010) 162–166.
[
[
[
7] J.M. Salas, M.A. Romero, M.P. Sánchez, M. Quirós, Metal complexes of [1,2,4]triazolo-
[
1,5-a]pyrimidine derivatives, Coord. Chem. Rev. 193–195 (1999) 1119–1142 and
Appendix A. Supplementary data
references therein.
8] A.B. Caballero, A. Rodríguez-Diéguez, L. Lezama, E. Barea, J.M. Salas, Structural and
magnetic properties of three novel complexes with the versatile ligand 5-methyl-
1
9] (a) A.B. Caballero, A. Rodríguez-Diéguez, J.K. Vieth, J.M. Salas, C. Janiak, Solvent-
dependent 2D-coordination polymers of Cu(I) containing a bridging triazolo-
pyrimidine ligand, Inorg. Chim. Acta 376 (2011) 674–678;
Figures S1 and S2; and Table S1. CCDC 842758 contains the supple-
,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one, Dalton Trans. 40 (2011) 5180–5187.
(
b) A.B. Caballero, A. Rodríguez-Diéguez, E. Barea, M. Quirós, J.M. Salas, Influence of
pseudohalide ligands on the structural versatility and properties of novel ternary
metal complexes with 1,2,4-triazolo[1,5-a]pyrimidine, CrystEngComm 12
(2010) 3038–3045;
1
to this article can be found online at doi:10.1016/j.inoche.2012.01.031.
(
c) N. Lekkas, N. Hadjiliadis, A. Garoufis, J. Kobe, P.V. Bernhardt, E.R.T. Tiekink,
Synthesis and characterization of Pd(II) and Pt(II) complexes with triazolopyri-
midine derivatives: The crystal structure of [Pd2L2Cl4] where L = 5,7-dimethyl-
References
1,2,4-triazolo[1,5-a]pyrimidine, Inorg. Chim. Acta 359 (2006) 4297–4303.
[
1] (a) A.D. Richards, A. Rodger, Synthetic metallomolecules as agents for the control
[10] A.B. Caballero, J.K. Maclaren, A. Rodríguez-Diéguez, I. Vidal, J.A. Dobado, J.M. Salas,
C. Janiak, Dinuclear silver(I) complexes for the design of metal-ligand networks
based on triazolopyrimidines, Dalton Trans. 40 (2011) 11845–11855.
[11] J.A.R. Navarro, M.A. Romero, J.M. Salas, M. Quirós, E.R.T. Tiekink, First example of
equatorial−equatorial disposition of end-to-end thiocyanate bridges in a polynu-
clear copper(II) complex and its relation to the very efficient transmission of the
magnetic interaction, Inorg. Chem. 36 (1997) 4988–4991.
[12] (a) P. Zhu, W. Gu, M.-L. Liu, H.-B. Song, X. Liu, Y.-Q. Gao, H.-Y. Duan, S.-P. Yan, D.-
Z. Liao, A family of 3D lanthanide oxalato-succinate with rare structures: 3D
host framework incorporating a 3D alkali metal guest lattice, CrystEngComm
11 (2009) 351–358;
of DNA structure, Chem. Soc. Rev. 36 (2007) 471–483;
(b) H.T. Chifotides, K.R. Dunbar, Interactions of metal-metal-bonded antitumor
active complexes with DNA fragments and DNA, Acc. Chem. Res. 38 (2005)
146–156.
[
[
2] M.J. Hannon, Supramolecular DNA recognition, Chem. Soc. Rev. 36 (2007) 280–295.
3] M. Legraverend, D.S. Grierson, Purines as potent and versatile small molecule
inhibitors of key biological targets, Bioorg. Med. Chem. 14 (2006) 3987–4006.
4] F. Zamora, M. Kunsman, M. Sabat, B. Lippert, Metal-stabilized rare tautomers of
nucleobases. 6-imino tautomer of adenine in a mixed nucleobase complex of
Hg(II), Inorg. Chem. 36 (1997) 1583–1594.
5] (a) I. Ramírez-Macías, C. Marín, J.M. Salas, A. Caballero, M.J. Rosales, N. Villegas, A.
Rodríguez-Diéguez, E. Barea, M. Sánchez-Moreno, Biological activity of three
novel complexes with the ligand 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-
[
[
(b) R.Q. Fang, X.M. Zhang, Diversity of coordination architecture of metal 4,5-
dicarboxyimidazole, Inorg. Chem. 45 (2006) 4801–4810;
(c) J.M. Ellsworth, K.L. Seward, M.D. Smith, H.C. zur Loye, Synthesis of mixed-
ligand coordination polymers containing 1,2,4-triazole, oxalate, and cadmium,
Solid State Sci. 10 (2008) 267–282.
7
8
(4H)-one against Leishmania spp, J. Antimicrob. Chemother. 66 (2011)
13–819 and references therein.;
(
b) A.B. Caballero, C. Marín, A. Rodríguez-Diéguez, I. Ramírez-Macías, E. Barea, M.
Sánchez-Moreno, J.M. Salas, In vitro and in vivo antiparasital activity against
Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-
[13] U. García-Couceiro, O. Castillo, J. Cepeda, M. Lanchas, A. Luque, S. Pérez-Yáñez, P.
Román, D. Vallejo-Sánchez, Influence of the synthetic conditions on the structural
diversity of extended manganese-oxalato-1,2-bis(4-pyridyl)ethylene systems,
Inorg. Chem. 49 (2010) 11346–11361.
7(4H)-one-based complexes, J. Inorg. Biochem. 105 (2011) 770–776 and
references therein.;